BioAge Labs, Inc share price logo

BioAge Labs, Inc Share Price

NASDAQ: BIOA

Small Cap

$16.61

-0.63

(-3.65%)

Live

as on

BioAge Labs, Inc Stock Performance

as on April 25, 2026 at 2:11 am IST

  • Day's Low

    Day's High

    $16.45
    $17.24
    downward going graph

    0.96%

    Downside

    3.79%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.67
    $24.00
    downward going graph

    77.90%

    Downside

    44.49%

    Upside

    downward going graph

BioAge Labs, Inc share price movements today

Previous Close
$17.24
Open
$17.18
Volume
182.2K
Day's Low - High
$16.45 - $17.24
52 Week Low - High
$3.67 - $24.00

BioAge Labs, Inc Historical Returns

1 Month Return
+ 7.01 %
3 Month Return
-8.35 %
1 Year Return
+ 310.48 %
3 Year Return
0 %
5 Year Return
0 %

BioAge Labs, Inc Stock Fundamentals & Key Indicators

Check BioAge Labs, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$815.1M

EPS (TTM)

-2.5999

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-27.09%

BioAge Labs, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioAge Labs, Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$815.1MNANA0.00%
BUY$25.1BNA20.5741.94%
HOLD$16.9B10.4%NA-24.58%
BUY$42.4BNA19.0615.11%
BUY$49.0B-31.95%19.2828.24%

Stock Returns calculator for BioAge Labs, Inc Stock including INR - Dollar returns

The BioAge Labs, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 10Y

BioAge Labs, Inc investment value today

Current value as on today

₹4,36,738

Returns

₹3,36,738

(+336.74%)

Returns from BioAge Labs, Inc Stock

₹2,95,476 (+295.48%)

Dollar Impact

₹41,262 (+41.26%)

BioAge Labs, Inc Stock’s Investor Sentiment and Interest

Search interest for BioAge Labs, Inc Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:4% versus previous 30 day period

BioAge Labs, Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
1
2
2
3
Gross Profit
-
-
-
-
-
-
1
2
2
3
Operating Income
-9
-13
-12
-15
-24
-25
-16
-24
-23
-28
EBITDA
-12
-18
-11
-13
-22
-20
-12
-21
-19
-28
Interest Expense
2
2
1
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-20
-12
-13
-23
-21
-12
-21
-20
-25
Income Tax Expense
-
-
1
0
-
-
-
-
-
-
Net Income
-14
-20
-12
-13
-23
-21
-12
-21
-20
-25
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-890.97%
-893.99%
-982.04%
-842.85%

BioAge Labs, Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2013
Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
1
2
8
14
-
-
-
8
Gross Profit
0
-4
0
-5
-7
-
-
-
8
Operating Income
-41
-35
-38
-29
-110
-39
-48
-78
-92
EBITDA
-38
-44
-33
-13
-88
-39
-55
-68
-92
Interest Expense
7
-
-
-
-
0
7
2
0
Depreciation
-
-
-
-
-
0
0
0
0
Income Before Tax
-33
-47
-41
-28
-102
-39
-63
-71
-80
Income Tax Expense
0
0
0
0
0
0
7
-71
-
Net Income
-33
-46
-37
-22
-98
-39
-63
-71
-80
Net Profit Margin
-1246.33%
-3008.45%
-1713.94%
-271.72%
-656.84%
0.00%
0.00%
0.00%
-896.11%

BioAge Labs, Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-20
-12
-13
-23
-21
-12
-21
-20
-25
Operating Cash Flow
-8
-15
-15
-14
-5
-17
-19
-16
-28
Investing Cash Flow
-
-
0
0
0
-77
-15
12
-14
Financing Cash Flow
-1
168
-2
190
24
-1
-1
-1
16
Change in Cash
-9
152
-18
175
19
-96
-37
-4
-26

BioAge Labs, Inc Annual Cash Flow

All numbers in Millions USD

Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-46
-37
-22
-98
-39
-63
-71
-80
Operating Cash Flow
-22
-32
-37
-29
-36
-37
-51
-81
Investing Cash Flow
-
-
-
-
0
0
0
-95
Financing Cash Flow
78
54
47
18
2
34
381
11
Change in Cash
-32
-44
9
-11
-33
-2
329
-165

Insights on BioAge Labs, Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, BIOA stock has moved up by 126.8%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BIOA has outperformed top 5 stocks with highest market-cap in its industry

About BioAge Labs, Inc

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
OrganisationBioAge Labs, Inc
Headquarters5885 Hollis Street, Emeryville, CA, United States, 94608
IndustryDrug Manufacturers - Specialty & Generic
CEODr. Kristen Fortney Ph.D.
E-voting on sharesClick here to vote

Key Management of BioAge Labs, Inc

Name

Title

Dr. Eric Morgen M.D.

Co-Founder, COO & Director

Dr. Paul D. Rubin M.D.

Chief Medical Officer & Executive VP of Research

Mr. BJ Sullivan Ph.D.

Chief Strategy Officer

Dr. Peng Leong M.B.A., Ph.D.

Chief Business Officer & Therapeutic Area Head of Brain Aging

Ms. Ann C. Neale RN BSN

Chief Development Officer

Dr. Kristen Fortney Ph.D.

Co-Founder, CEO, President, Treasurer, Secretary & Director

Dr. Dov A. Goldstein M.B.A., M.D.

Chief Financial Officer

Mr. Shane Barton CPA

Senior Vice President of Finance & Accounting

Mr. Rusty Montgomery Ph.D.

Senior Vice President of Research

Ms. Julie Gammelgard

Senior Vice President of People

FAQs

What is BioAge Labs, Inc share price today?

BioAge Labs, Inc share price today is $16.61 as on . BioAge Labs, Inc share today touched a day high of $17.24 and a low of $16.45.

What is the 52 week high and 52 week low for BioAge Labs, Inc share?

BioAge Labs, Inc share touched a 52 week high of $24 on and a 52 week low of $3.67 on . BioAge Labs, Inc stock price today i.e. is trending at $16.61,which is 30.79% down from its 52 week high and 352.59% up from its 52 week low.

What is BioAge Labs, Inc's market capitalisation today?

BioAge Labs, Inc market capitalisation is $0.00T as on .

How to invest in BioAge Labs, Inc Stock (BIOA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioAge Labs, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioAge Labs, Inc Shares that will get you 0.0903 shares as per BioAge Labs, Inc share price of $16.61 per share as on April 24, 2026 at 8:41 pm IST.

What is the minimum amount required to buy BioAge Labs, Inc Stock (BIOA) from India?

Indian investors can start investing in BioAge Labs, Inc (BIOA) shares with as little as ₹94.228 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in BioAge Labs, Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on BioAge Labs, Inc share’s latest price of $16.61 as on April 24, 2026 at 8:41 pm IST, you will get 0.6020 shares of BioAge Labs, Inc. Learn more about fractional shares .